Holen Sie sich die Stockscreener-App
29.77
0.03%
0.010
Arcutis Biotherapeutics Inc Aktie (ARQT) Neueste Nachrichten
What Makes Arcutis Biotherapeutics, Inc. (ARQT) a Strong Momentum Stock: Buy Now? - sharewise.com
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected - simplywall.st
Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri - BioSpace
Arcutis Biotherapeutics Appoints Amit Munshi as New Director - TipRanks
Arcutis Biotherapeutics Announces Board Changes - TradingView
Amit Munshi joins Arcutis board as founder Chaudhuri retires By Investing.com - Investing.com India
Arcutis strengthens board of directors with new appointment of Amit Munshi - marketscreener.com
Arcutis Strengthens Board of Directors with New Appointment - GlobeNewswire
Arcutis Biotherapeutics | 12/8/25 - Channel 13 Las Vegas News KTNV
Arcutis Biotherapeutics: The Earnings Inflection Has Arrived (ARQT) - Seeking Alpha
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Arcutis Biotherapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
XTX Topco Ltd Reduces Position in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Downgraded to "Buy" Rating by Wall Street Zen - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Reaches New 1-Year HighStill a Buy? - MarketBeat
What risks investors should watch in Arcutis Biotherapeutics Inc. stockRate Cut & Reliable Breakout Forecasts - Newser
Howard Welgus Sells 10,000 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 1,657 Shares - MarketBeat
Arcutis Biotherapeutics stock hits 52-week high at 31.29 USD - Investing.com
Arcutis Biotherapeutics stock hits 52-week high at 31.29 USD By Investing.com - Investing.com Canada
Insider Sell: Howard Welgus Sells 10,000 Shares of Arcutis Bioth - GuruFocus
Assessing Arcutis Biotherapeutics (ARQT) Valuation After Its Strong 1-Year Share Price Surge - Yahoo Finance
Arcutis Biotherapeutics Insider Sold Shares Worth $302,133, According to a Recent SEC Filing - marketscreener.com
AZN's Baxdrostat Gets FDA Priority Tag for Uncontrolled Hypertension - Finviz
Is the Options Market Predicting a Spike in Arcutis Biotherapeutics Stock? - sharewise.com
Arcutis Biotherapeutics: Behind The Big Rally (NASDAQ:ARQT) - Seeking Alpha
(ARQT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
American Century Companies Inc. Purchases 71,815 Shares of Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Arcutis Biotherapeutics Inc (ARQT) Stock Price, Trades & News - GuruFocus
Arcutis Biotherapeutics, Inc. $ARQT is Tejara Capital Ltd's 2nd Largest Position - MarketBeat
Mizuho Maintains Arcutis Biotherapeutics (ARQT) Outperform Recommendation - Nasdaq
Mizuho raises Arcutis Biotherapeutics stock price target on strong Zoryve sales By Investing.com - Investing.com South Africa
Mizuho raises Arcutis Biotherapeutics stock price target on strong Zoryve sales - Investing.com Nigeria
Mizuho Raises Price Target on Arcutis Biotherapeutics (ARQT) to $37 | ARQT Stock News - GuruFocus
Geode Capital Management LLC Has $36.21 Million Stake in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Franklin Resources Inc. Sells 28,990 Shares of Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
DNB Asset Management AS Buys Shares of 28,171 Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Arcutis Biotherapeutics Surges 112% in 2025 Is the Rally Justified After Regulatory Milestones? - Yahoo Finance
Arcutis Biotherapeutics stock reaches 52-week high at 31.1 USD By Investing.com - Investing.com South Africa
Arcutis Biotherapeutics stock reaches 52-week high at 31.1 USD - Investing.com
Arcutis Biotherapeutics (ARQT) Is Up 12.6% After FDA Accepts ZORYVE sNDA for Pediatric Psoriasis Review - Yahoo Finance
Intech Investment Management LLC Has $1.21 Million Stock Position in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Why Shares in Arcutis Biotherapeutics Surged Again This Week - AOL.com
Arcutis Biotherapeutics director Lin sells $777,955 in shares By Investing.com - Investing.com UK
Arcutis Biotherapeutics director Lin sells $777,955 in shares - Investing.com
Arcutis Biotherapeutics Director Sells Shares - TradingView
Dir Lin Sells 25,272 ($778K) Of Arcutis Biotherapeutics Inc [ARQT] - TradingView
Biogen Inks Research Deal With Dayra to Boost Immunology Pipeline - Zacks Investment Research
Arcutis Rides ZORYVE Sales To Outsized Stock Gains - Finimize
Arcutis Biotherapeutics Insider Sold Shares Worth $1,517,405, According to a Recent SEC Filing - marketscreener.com
Watanabe Todd sells Arcutis Biotherapeutics (ARQT) shares for $1.5m By Investing.com - Investing.com Canada
Watanabe Todd sells Arcutis Biotherapeutics (ARQT) shares for $1.5m - Investing.com India
Arcutis Biotherapeutics Director Todd Watanabe Sells 50,000 Shares - TradingView
CEO Watanabe Sells 50,000 ($1.5M) Of Arcutis Biotherapeutics Inc [ARQT] - TradingView
CEO Watanabe Files To Sell 48,945 Of Arcutis Biotherapeutics Inc [ARQT] - TradingView
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):